Kura Oncology and Kyowa Kirin reported positive Phase 2 results for ziftomenib in AML and plan Phase 3 trials, with an NDA ...

The CIX Startup Awards is a showcase of Canada’s premier startups that are selected and recognized by North American investors. Award recipients will pitch in person this year at the CIX Summit on ...

PhaseV, a pioneer in software and machine learning (ML) for advanced clinical development optimization, announced today that senior company executives will present at five key industry conferences in ...

CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biotechnology company developing a pipeline of regRNA-targeting antisense oligonucleotide (ASO) therapies to upregulate gene ...

SAB BIO, (“SAB BIO”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human ...